| Dr Jason Patrick Izard, MD | |
|
1959 Ne Pacific St, Box 356510, Seattle, WA 98195-0001 | |
| (206) 543-4740 | |
| Not Available |
| Full Name | Dr Jason Patrick Izard |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1174887657 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | FE60221930 (Washington) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jason Patrick Izard, MD 1959 Ne Pacific St, Box 356510, Seattle, WA 98195-0001 Ph: (206) 543-4740 | Dr Jason Patrick Izard, MD 1959 Ne Pacific St, Box 356510, Seattle, WA 98195-0001 Ph: (206) 543-4740 |
News Archive
A team of scientists at the University of California, San Diego School of Medicine have identified a network of genes that initiate and manage cilia formation. Although scientists have known about cilia for decades, only recently have they discovered their role in disease. This new discovery, which may lead to new therapies for ciliopathies, will appear in the April 15 edition of Nature.
According to a new study, a genetic mutation thought to be responsible for the rare hereditary brain disorder Kufs disease is finally identified. The research was carried out by Dr Melanie Bahlo and her team at the Walter and Eliza Hall Institute's bioinformatics department in Parkville, Australia, in partnership with neurologist and epilepsy specialists Professor Sam Berkovic and Dr Todor Arsov from the University of Melbourne, Australia.
Ablexis, LLC, a biotechnology company dedicated to developing an innovative, next-generation platform for antibody drug discovery, announced today that it has completed a $12 million Series A financing. The round was led by Third Rock Ventures and included Pfizer Venture Investments. Proceeds from the financing will be used to continue advancing Ablexis' proprietary AlivaMab Mouse transgenic mouse platform for the discovery of human therapeutic antibodies.
African Americans at the end of life have significantly higher rates of hospital admission, emergency department (ED) visits, and discontinuing (also known as disenrolling from) hospice care than whites, according to a new study by researchers at the Icahn School of Medicine at Mount Sinai published today by the Journal of the American Geriatrics Society.
› Verified 7 days ago
Dr. Sandra Jane Hadjinian, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St., Seattle, WA 98195 Phone: 206-520-5000 | |
Dr. Steven Han, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104 Phone: 206-215-2580 Fax: 206-215-2581 | |
John Steele Mullen, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 515 Minor Ave, Suite 200, Seattle, WA 98104 Phone: 206-215-2580 Fax: 206-215-2581 | |
Jeffrey M Mccracken, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 747 Broadway, Seattle, WA 98122 Phone: 206-386-2043 Fax: 206-386-2508 | |
Dr. Carol Collins, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 272 Health Sciences, 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-616-3294 | |
Dr. Daniel Warren Smith, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 9709 3rd Ave Ne, Seattle, WA 98115 Phone: 206-860-4944 | |
Tristan Marriner Nicholson, MD, PHD Urology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Seattle, WA 98195 Phone: 206-520-5000 |